Physician profile
Jeong H Kim
NPI 1861591786
$3,362.11
in general payments reported to CMS, 2019-2025
21 companies · $698 in 2025
The $698 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $345 · 2021: $680 · 2022: $665 · 2023: $319 · 2024: $255 · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,272.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orexo US, INC. | $1,230.02 | 2019-2025 | Zubsolv |
| Indivior INC. | $298.51 | 2019-2025 | Sublocade |
| Alkermes, INC. | $256.76 | 2021-2024 | Aristada, Lybalvi, Vivitrol |
| Braeburn INC. | $231.37 | 2023-2025 | Brixadi |
| Abbott Laboratories | $200.36 | 2025 | Amplatzer Amulet |
| Boehringer Ingelheim Pharmaceuticals, INC. | $183.26 | 2019-2022 | |
| Pfizer INC. | $159.24 | 2020-2021 | |
| Mdd US Operations, LLC | $142.50 | 2019 | |
| Novo Nordisk INC | $119.03 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $98.76 | 2019-2022 | |
| Abbvie INC. | $87.57 | 2020-2023 | |
| Astrazeneca Pharmaceuticals Lp | $84.26 | 2020 | |
| Antares Pharma, INC. | $67.28 | 2022-2023 | Tlando, Nocdurna, Xyosted |
| Lilly USA, LLC | $48.62 | 2019 | |
| Irhythm Technologies, INC. | $33.71 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $24.80 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.22 | 2019 | |
| Amarin Pharma, INC. | $19.66 | 2021 | |
| Exact Sciences Corporation | $19.47 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $18.40 | 2022 | |
| Halozyme INC | $17.31 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeong Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.